We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Forgotten Vital Stain Identifies Resistant TB

By LabMedica International staff writers
Posted on 14 Aug 2012
Vital staining with fluorescein diacetate (FDA) stains only living Mycobacterium tuberculosis tuberculosis bacilli so that only those bacilli resistant to treatment are seen.

Scientists improved the detection of the luminous bacilli by replacing the classical fluorescence microscope with its light-emitting diode (LED) counterpart. More...
Together with colleagues in Bangladesh, scientists at the Antwerp Institute of Tropical Medicine (Belgium) tested the approach in the field for four years. If after treatment the FDA-test was negative, in 95% of cases more elaborate tests did not find active bacilli in the patient's sputum. And if the test was positive, a resistant bacillus had been found.

Tuberculosis bacilli that have become resistant to major antibiotics are a serious threat to world health. Checking smears under the microscope is the recommended technique for TB screening, but it cannot differentiate between living and dead bacilli. Therefore, it is not possible to know whether the bacilli observed are cadavers after a successful treatment, or resistant survivors. Only if the numbers do not decrease after a long wait, you know you are dealing with a resistant strain. But all that time the patient remains contagious.

With high-tech PCR technology, one can immediately ascertain if the bacillus is from a resistant strain, but in practice and certainly in resource-limited countries, this is unfeasible. It also is impossible to cultivate every sample and then bombard it with every possible antibiotic to survey which ones still work for that individual patient.

In 1991, a tuberculosis bug in New York was found to be resistant to 11 antibiotics. Cases have been reported where every antibiotic was useless. So far, these “omniresistant” bacilli each time perished with their host before they could spread. So far, that is. The highest numbers were all registered in the former Soviet Union.

Tuberculosis bacilli that have become resistant against the major antibiotics are a serious threat to world health.

To prevent an epidemic of difficult-to-treat tuberculosis, resistant cases, which do not react to the normal treatment, need to be recognized as early as possible, and immediately treated with second-line antibiotics that still work. But the laboratory tests to identify resistant TB bugs are cumbersome––the WHO estimates that in 2009 only 11% of multiresistant cases were discovered.

The FDA staining approach of Armand Van Deun and colleagues in the field for four years is very promising especially as it can be used in low-resource countries.

Related Links:
Antwerp Institute of Tropical Medicine
World Health Organization


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The cell-based tests bring artificial intelligence to transplant outcome care (Photo courtesy of iStock)

AI-Enhanced Cell-Based Blood Tests to Improve Predictive Accuracy for Complex Transplant Outcomes

Managing immunosuppressive drugs in transplant patients is a delicate challenge. Insufficient medication can lead to rejection, which may be cell- or antibody-mediated, while excess immunosuppression raises... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: A saliva test can help predict future metabolic health concerns including diabetes and obesity (Photo courtesy of 123RF)

Saliva Test to Enable Early Detection of Diabetes and Obesity

Type 2 diabetes affects about 400 million people globally and is typically diagnosed through elevated blood glucose levels. However, conditions like insulin resistance and hyperinsulinemia may begin developing... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.